7-(4-fluorophenyl)-2-[(2-methylpyrimidin-5-yl)oxymethyl]thieno[3,2-b]pyridine-5-carboxamide

ID: ALA4557272

PubChem CID: 155554668

Max Phase: Preclinical

Molecular Formula: C20H15FN4O2S

Molecular Weight: 394.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncc(OCc2cc3nc(C(N)=O)cc(-c4ccc(F)cc4)c3s2)cn1

Standard InChI:  InChI=1S/C20H15FN4O2S/c1-11-23-8-14(9-24-11)27-10-15-6-17-19(28-15)16(7-18(25-17)20(22)26)12-2-4-13(21)5-3-12/h2-9H,10H2,1H3,(H2,22,26)

Standard InChI Key:  HMTUWDMGNWHLSV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   31.6226   -4.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3322   -3.6544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3294   -2.8318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6208   -2.4265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6242   -4.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9148   -5.2867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9142   -6.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6224   -6.5127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3325   -6.0999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3296   -5.2848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9145   -3.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9157   -2.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1395   -2.5849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6585   -3.2448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1376   -3.9060    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   28.8414   -3.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4317   -3.9507    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0355   -2.4205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7448   -2.8264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0325   -1.6033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6145   -3.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2101   -3.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3937   -3.2411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9832   -3.9488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3952   -4.6594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2103   -4.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6233   -7.3299    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.1660   -3.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4 12  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 14 16  1  0
 16 17  1  0
  3 18  1  0
 18 19  1  0
 18 20  2  0
 17 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  8 27  1  0
 24 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4557272

    ---

Associated Targets(non-human)

Grm2 Metabotropic glutamate receptor 2 (1326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.43Molecular Weight (Monoisotopic): 394.0900AlogP: 3.88#Rotatable Bonds: 5
Polar Surface Area: 90.99Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.05CX LogP: 3.24CX LogD: 3.24
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.12

References

1. Childress ES, Wieting JM, Felts AS, Breiner MM, Long MF, Luscombe VB, Rodriguez AL, Cho HP, Blobaum AL, Niswender CM, Emmitte KA, Conn PJ, Lindsley CW..  (2018)  Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores.,  62  (1): [PMID:30350962] [10.1021/acs.jmedchem.8b01266]

Source